Lv1
60 积分 2025-04-16 加入
Benefits and Risks Associated With Continuation of Anti–Tumor Necrosis Factor After 24 Weeks of Pregnancy in Women With Inflammatory Bowel Disease
1天前
待确认
Women’s Willingness to Accept Risks of Medication for Inflammatory Bowel Disease During Pregnancy
1个月前
已完结
Protease inhibitor-based antiretroviral therapy in pregnancy: effects on hormones, placenta, and decidua
2个月前
已完结
Risk of Congenital Anomalies with Dolutegravir-Based Anti-retroviral Regimens: A Systematic Review and Meta-analysis
2个月前
已完结
Risk of Congenital Anomalies with Dolutegravir-Based Anti-retroviral Regimens: A Systematic Review and Meta-analysis
2个月前
已关闭
皖公网安备34019202002308
